Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-086X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies ; volume:39 ; number:6 ; day:30 ; month:12 ; year:2015 ; pages:801-814 ; date:6.2016
CardioVascular and interventional radiology ; 39, Heft 6 (30.12.2015), 801-814, 6.2016
- Creator
-
Burgmans, Mark C.
- Contributor
-
Leede, Eleonora M. de
Martini, Christian H.
Kapiteijn, Ellen
Vahrmeijer, Alexander L.
Erkel, Arian R. van
SpringerLink (Online service)
- DOI
-
10.1007/s00270-015-1276-z
- URN
-
urn:nbn:de:1111-201605075136
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Burgmans, Mark C.
- Leede, Eleonora M. de
- Martini, Christian H.
- Kapiteijn, Ellen
- Vahrmeijer, Alexander L.
- Erkel, Arian R. van
- SpringerLink (Online service)
Other Objects (12)
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma
Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review
New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
Stereotactic percutaneous electrochemotherapy as primary aproach for unresectable large HCC at the hepatic hilum
Heparin reversal with protamine sulfate after Percutaneous Hepatic Perfusion (PHP): is less more?
Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques
Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma
Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma
Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review
New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
Stereotactic percutaneous electrochemotherapy as primary aproach for unresectable large HCC at the hepatic hilum
Heparin reversal with protamine sulfate after Percutaneous Hepatic Perfusion (PHP): is less more?
Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques
Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma
Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma
Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review
New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
Stereotactic percutaneous electrochemotherapy as primary aproach for unresectable large HCC at the hepatic hilum
Heparin reversal with protamine sulfate after Percutaneous Hepatic Perfusion (PHP): is less more?
Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques
Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma
Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma